Vikderma - Company finances
|
EUR
|
2021
From: 2021-10-20
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-31
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 403 | 79,989 | 226,000 | 437,551 | 644,928 |
| Profit before tax | - | - | - | 107,006 | 218,767 |
| Net profit | -1,420 | 11,440 | 74,748 | 95,199 | 184,177 |
| Equity | 1,080 | 12,521 | 87,269 | 182,468 | 366,644 |
| Liabilities | 12,813 | 18,482 | 7,507 | 19,478 | 54,994 |
| Non-current assets | 0 | 0 | 0 | 18,164 | 51,650 |
| Current assets | 13,893 | 31,003 | 94,776 | 183,782 | 369,294 |
| Total assets | 13,893 | 31,003 | 94,776 | 201,946 | 420,944 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 45,876 | 91,539 | 152,758 |
| Social insurance contributions | - | - | 2,956 | 9,660 | 19,416 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | +19748.4% | +182.5% | +93.6% | +47.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -10.2% | 36.9% | 78.9% | 47.1% | 43.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -131.5% | 91.4% | 85.7% | 52.2% | 50.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -352.4% | 14.3% | 33.1% | 21.8% | 28.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | 24.5% | 33.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 11.9 | 1.5 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 202 | 30,964 | 67,801 | 119,331 | 128,986 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vikderma - Social security debts
The company had no debts to Sodra
Vikderma - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-10 | 2026-07-26 | 12.0 |
| 2026-02-21 | 2026-02-21 | 1.1 |
| 2026-01-29 | 2026-02-16 | 1.1 |
| 2026-01-16 | 2026-01-22 | 1.1 |
| 2026-01-11 | 2026-01-15 | 0.14 |
| 2025-05-01 | 2025-05-01 | 24.94 |
| 2024-12-19 | 2024-12-23 | 0.26 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vikderma, UAB (code 305920240) is a Private Limited Liability Company engaged in the wholesale of perfume and cosmetics. In 2025, the latest financial year, the company generated revenue of €644.9K and net profit of €184.2K, with a profit margin of 28.6%. Revenue increased by 47.4% year on year and by 185.4% over two years, indicating a strong growth trajectory. Profitability also improved over the period, rising from €74.7K in 2023 to €95.2K in 2024 and €184.2K in 2025. Balance sheet strength remained solid: total assets reached €420.9K, equity €366.6K and liabilities €55.0K at the end of 2025. The equity ratio was 87.1%, and debt-to-equity stood at 0.15, showing a lightly leveraged structure. Asset turnover was 1.53x, while return on equity was 50.2% and return on assets 43.8%, reflecting efficient use of capital and assets. Revenue per employee was €129.0K and profit per employee €36.8K in 2025.